IL-4 prevents adenosine-mediated immunoregulation by inhibiting CD39 expression
Open Access
- 22 June 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (12)
Abstract
The ectonucleotidase CD39 functions as a checkpoint in purinergic signaling on effector T cells. By depleting eATP and initiating the generation of adenosine, it impairs memory cell development and contributes to T cell exhaustion, thereby causing defective tumor immunity and deficient T cell responses in older adults who have increased CD39 expression. Tuning enzymatic activity of CD39 and targeting the transcriptional regulation of ENTPD1 can be used to modulate purinergic signaling. Here, we describe that STAT6 phosphorylation downstream of IL-4 signaling represses CD39 expression on activated T cells by inducing a transcription factor network including GATA3, GFI1, and YY1. GATA3 suppresses ENTPD1 transcription through prevention of RUNX3 recruitment to the ENTPD1 promoter. Conversely, pharmacological STAT6 inhibition decreases T cell effector functions via increased CD39 expression, resulting in the defective signaling of P2X receptors by ATP and stimulation of A2A receptors by adenosine. Our studies suggest that inhibiting the STAT6 pathway to increase CD39 expression has the potential to treat autoimmune disease while stimulation of the pathway could improve T cell immunity.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (AI129191)
- National Institute of Allergy and Infectious Diseases (AI057266)
- National Institute of Allergy and Infectious Diseases (AI108891)
This publication has 45 references indexed in Scilit:
- CD39 and CD73 in immunity and inflammationTrends in Molecular Medicine, 2013
- AMP Is an Adenosine A1 Receptor AgonistJournal of Biological Chemistry, 2012
- T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elementsNature Communications, 2012
- Inhibition of Suppressive T Cell Factor 1 (TCF-1) Isoforms in Naive CD4+ T Cells Is Mediated by IL-4/STAT6 SignalingJournal of Biological Chemistry, 2011
- cAMP/CREB-mediated Transcriptional Regulation of Ectonucleoside Triphosphate Diphosphohydrolase 1 (CD39) ExpressionJournal of Biological Chemistry, 2010
- The Transcription Factor GATA3 Actively Represses RUNX3 Protein-Regulated Production of Interferon-γImmunity, 2010
- The Runx3 Transcription Factor Augments Th1 and Down-Modulates Th2 Phenotypes by Interacting with and Attenuating GATA3The Journal of Immunology, 2009
- CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel diseaseProceedings of the National Academy of Sciences, 2009
- Central role of Sp1-regulated CD39 in hypoxia/ischemia protectionBlood, 2009
- Deletion of Cd39/Entpd1 Results in Hepatic Insulin ResistanceDiabetes, 2008